300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Oil and Gas
Retail
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
China
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Paraguay
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Bolivia
Belize
Algeria
Italy
Estonia
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Bahamas
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Fidji Simo, Angel Investor

Fidji Simo

Angel Investor

Palo Alto, United States

Fidji Simo is a seed investor in Palo Alto focused on Software and Health Care. Fidji Simo is the CEO and Chair of the Board of Directors of Instacart. She previously worked at Facebook as a Head of the Facebook App. Fidji Simo attended HEC Paris.

Total investments:
24
Last investment:
Lead investor:
0%

Last updated:

Industries Fidji Simo invests in

SoftwareHealth CareInternetWellnessBlockchain

Stages Fidji Simo invests in

SeedSeries ASeries BPre-SeedVenture - Series Unknown

Countries Fidji Simo invests in

United StatesUnited KingdomCanadaFranceIsrael

Round sizes

Seed $1.2M–$12MSeries A $10M–$48MSeries B $28M–$250M

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$1.2M–$12M
Series A
$10M–$48M
Series B
$28M–$250M

Investment Focus

Industry

  • Software 7 (29%)
  • Health Care 4 (17%)
  • Internet 2 (8%)
  • Wellness 2 (8%)
  • Blockchain 2 (8%)
See all 47 industries →

Stage

  • Seed 7 (29%)
  • Series A 7 (29%)
  • Series B 4 (17%)
  • Pre-Seed 2 (8%)
  • Venture - Series Unknown 2 (8%)
See all 6 stages →

Country

  • United States 15 (63%)
  • United Kingdom 2 (8%)
  • Canada 1 (4%)
  • France 1 (4%)
  • Israel 1 (4%)
See all 6 countries →

Investments

CompanyDescriptionRoundLinks
The Academy provides a unique path for the next generation of IT leaders coming out of high school. $42M / Venture - Series Unknown / Sep 22, 2026
BuildForever build products that feel personal, magical and deeply human. $9.5M / Seed / Apr 21, 2026
Breezy is a Los Angeles-based startup offering an AI operating system tailored for residential real estate professionals. It automates workflows like creating branded comps, tracking client conversations, managing pipelines, and analyzing property development potential via its Underbuilt tool. $10M / Pre-Seed / Feb 02, 2026
Beacon Software is a holding company that specializes in the acquisition of software businesses. $250M / Series B / Nov 04, 2025
Brain Co. is a San Francisco-based AI company, that partners with large enterprises and governments to build secure, impactful AI platforms and applications for real-world problems. It delivers faster, cost-saving, and reliable AI solutions, including automation and optimization across sectors like healthcare, energy, and government. R $30M / Series A / Sep 10, 2025
Somite is a mission to transform the lives of millions of people by leveraging AI to produce human tissue for cell-based therapies. $47M / Series A / May 13, 2025
Owner provides a suite of tools designed to assist local restaurant owners in enhancing their sales and online visibility. The platform features solutions like mobile ordering and customer rewards, which aim to improve customer engagement. Additionally, Owner offers a free website grading tool that helps restaurants evaluate their online presenceand identify areas for improvement. These resources empower restaurant owners to optimize their marketing strategies and connect more effectively with their customers. By focusing on practical solutions, Owner supports the growth and development of local dining establishments. $120M / Series C / May 13, 2025
Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed withworld-class experts in reproductive medicine and genetics to give its clients the most accurate results.Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California. $12M / Seed / Dec 05, 2023
SaaS Practice Management Software for Dental Practices $6M / Seed / Nov 07, 2022
GOURMEY is France's pioneering cultivated meat company. We create sustainable cultivated meat delights for an uncompromising and conscious generation. $47.6M / Series A / Oct 05, 2022
See all 24 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Oil and Gas
Retail
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
China
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Paraguay
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Bolivia
Belize
Algeria
Italy
Estonia
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Bahamas
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Fidji Simo invest in?

Fidji Simo invests primarily in Software, Health Care and Internet startups, most often at Seed and Series A stage. Most of the 24 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Fidji Simo invest in?

Fidji Simo typically joins rounds of $1.2M–$12M at Seed, $10M–$48M at Series A and $28M–$250M at Series B. These are whole funding-round sizes, not Fidji Simo's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Fidji Simo took part in.

How do I contact Fidji Simo?

Public channels for Fidji Simo include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Fidji Simo last invest?

The most recent investment recorded for Fidji Simo closed in Sep 2026. Shizune tracks 24 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Fidji Simo Fidji Simo Find email